Omega+ Ashwagandha
OMEGA-3
- Omega-3 fish oil is a dietary supplement derived from the tissues of oily fish such as salmon, mackerel, and sardines.
- Omega-3 fatty acids are crucial for various functions in the body, including brain health, heart health, and inflammation regulation.
- Consumption of omega-3 fish oil is associated with reduced risk factors for heart disease, such as lowering triglyceride levels and blood pressure.
- Fish oil supplements have been associated with reducing inflammation, which can be beneficial for conditions like arthritis.
ASHWAGANDHA
- Ashwagandha has been used for centuries for its various health benefits.
- It is believed to enhance stamina, reduce fatigue, and improve overall energy levels.
- It may help improve cognitive function and memory.
- Ashwagandha is known for its ability to reduce cortisol levels, the body’s primary stress hormone.
Original price was: ₹2,298.00.₹1,280.00Current price is: ₹1,280.00.
OMEGA-3
Potent dosages of EPA (560mg) and DHA (400mg), make it a complete triple strength formula, facilitating the functioning of your heart, brain, eyes, and joints.
- Triple strength formula
- Provides faster muscle recovery after workout
- Reduces joint inflammation
- Promotes heart health
- Boosts brain function
- Improves eye health
ASHWAGANDHA
A single Xvita Ashwagandha Tablets contains the Ashwagandha herb along with the excipients that make it possible for the product to function within the consumer’s body. Excipients refer to those chemically or biologically inactive substances that aid in the proper mixing and breakdown of the herb within the body, thus leading to the discharge of its components that then flow through the blood to the respective organs.
Xvita Ashwagandha Tablets Support Cognitive Health Besides Helping Develop A Peaceful State Of Mind By Balancing Cortisol, A Stress-Releasing Hormone. In This Fast-Paced And Competitive World, This Dietary Supplement Acts As A Savior That Boosts Your Energy, Promotes Vigor, And Vitality.
Reviews
There are no reviews yet.